SRx Health Solutions Statistics
Total Valuation
SRXH has a market cap or net worth of $44.64 million. The enterprise value is $43.87 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRXH has 358.26 million shares outstanding. The number of shares has increased by 312.45% in one year.
| Current Share Class | 358.26M |
| Shares Outstanding | 358.26M |
| Shares Change (YoY) | +312.45% |
| Shares Change (QoQ) | +786.47% |
| Owned by Insiders (%) | 6.95% |
| Owned by Institutions (%) | 0.51% |
| Float | 333.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.70 |
| Forward PS | n/a |
| PB Ratio | 3.39 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.24.
| Current Ratio | 1.72 |
| Quick Ratio | 1.19 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -75.00% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $1.16M |
| Profits Per Employee | -$4.17M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SRXH has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.77% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -73.77% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 50.21 |
| Average Volume (20 Days) | 33,203,341 |
Short Selling Information
The latest short interest is 13.30 million, so 3.71% of the outstanding shares have been sold short.
| Short Interest | 13.30M |
| Short Previous Month | 9.53M |
| Short % of Shares Out | 3.71% |
| Short % of Float | 3.99% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
In the last 12 months, SRXH had revenue of $12.78 million and -$45.87 million in losses. Loss per share was -$0.50.
| Revenue | 12.78M |
| Gross Profit | 3.86M |
| Operating Income | -13.71M |
| Pretax Income | -23.63M |
| Net Income | -45.87M |
| EBITDA | -15.47M |
| EBIT | -13.71M |
| Loss Per Share | -$0.50 |
Full Income StatementBalance Sheet
The company has $26.07 million in cash and $22.62 million in debt, with a net cash position of $3.45 million or $0.01 per share.
| Cash & Cash Equivalents | 26.07M |
| Total Debt | 22.62M |
| Net Cash | 3.45M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 18.29M |
| Book Value Per Share | 0.04 |
| Working Capital | 18.07M |
Full Balance SheetCash Flow
| Operating Cash Flow | -26.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | -1.75M |
| Net Borrowing | 7.11M |
| Free Cash Flow | -26.29M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
| Gross Margin | 30.16% |
| Operating Margin | -107.31% |
| Pretax Margin | -184.88% |
| Profit Margin | n/a |
| EBITDA Margin | -121.03% |
| EBIT Margin | -107.31% |
| FCF Margin | n/a |
